Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis harrisbricken Views: 477

-

Israel is among the world’s leaders in the medical and non-medical cannabis research and development (R&D). Israeli scientists made breakthrough discoveries in the mid-twentieth century, paving the way for the country being one of the early adopters of a medical cannabis program. Now, Israel is gearing up to legalize recreational cannabis and export cannabis across the globe and become one of the leading nations in the global cannabis trade. In this post, I briefly examine the history of cannabis in Israel and what the future may hold for the country.

While cannabis has been used for thousands of years in ancient sites in Israel, the country’s developments in the last few decades have been extremely significant. In the 1960s, Israeli chemist Raphael Mechoulam began making breakthroughs in researching cannabis, becoming the first researcher to isolate the THC compound. Fast forwarding a few decades, in the 1990s, the Israeli government began researching and studying potential reforms for cannabis in Israel.

Cannabis in Israel has long been regulated under the Dangerous Drugs Ordinance as a dangerous drug (sort of like cannabis in the US and the Controlled Substances Act). Nevertheless, the first medical cannabis authorizations were allowed in Israel in the 1990s, making Israel one of the first nations to legalize any form of cannabis for medical use. In 2013, the Israeli Medical Cannabis Agency, an agency housed within the Israeli Ministry of Health, was established to further regulate medical cannabis. More recently, the Israeli government decriminalized possession of certain amounts of cannabis for recreational purposes, but full-scale legalization of recreational cannabis has not yet occurred.

While Israel has by far been one of the leading nations with respect to medical cannabis and cannabis R&D, two recent developments will position Israel to be a leader in the global cannabis trade.

First, Israel is gearing up to be a leading exporter of medical cannabis. Back in 2017, we wrote about how Israel began the process of exporting medical marijuana. The process has been long and arduous, but earlier this year, the export process for medical cannabis was approved and Israel is therefore one of the few countries that’s authorized the export of medical cannabis (for reference, the United States has not). There are many countries globally that authorize importation of cannabis (in fact, Israel just surpassed Germany as the world’s largest importer of medical cannabis), and Israeli cannabis will likely do very well globally.

Second, the country is shifting towards a full-scale recreational market. In late June 2020, the Israeli Knesset (its parliament) voted to advance two bills that would legalize cannabis for recreational purposes. This vote was just a preliminary vote and there are still some hurdles to clear before this becomes a reality, but it’s a major step in the right direction for legalizing cannabis for recreational purposes.

The next few years are likely to see further significant progress in Israel’s cannabis market, both globally and domestically. Stay tuned to the Canna Law Blog for more updates.

In the meantime, for more on international cannabis, check out the following:

Israel: Cannabis Powerhouse on Harris Bricken.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.